Levothyroxine and Pregnancy: Why Your Dose Almost Always Goes Up

Pregnancy increases thyroid hormone demand, and women already on levothyroxine typically need a 20% to 50% dose increase by the first trimester. The American Thyroid Association recommends an empiric dose increase as soon as pregnancy is confirmed and TSH testing every four weeks through mid-pregnancy.

Why pregnancy changes thyroid medication needs

Three things happen in early pregnancy that increase thyroid hormone demand [C1]:

1. Thyroid-binding globulin doubles. Estrogen raises TBG, which means more thyroid hormone is bound and less is bioavailable — so the body needs more total hormone to keep the free fraction normal.
2. hCG cross-stimulates the TSH receptor. Especially in the first trimester, the placenta's hCG mimics TSH and stimulates the thyroid. In a healthy gland this is enough; in a thyroidectomized or Hashimoto's-damaged gland, it's not.
3. The baby needs thyroid hormone too. The fetal thyroid does not start producing meaningful hormone until weeks 16 to 20. Until then, the developing brain depends entirely on mom's T4 crossing the placenta [C1][C6].

The net effect: women already on levothyroxine usually need 20–50% more, starting in the first weeks of pregnancy [C1][C2].

What the ATA pregnancy guideline recommends

The 2017 American Thyroid Association guidelines are the authoritative reference [C1]. Key points:

• Pre-conception: Aim for TSH <2.5 mIU/L in women trying to conceive who are on levothyroxine [C1].
• First trimester: Target TSH 0.1 to 2.5 mIU/L. Many women on levothyroxine need a dose increase of about 20–30% as soon as pregnancy is confirmed [C1].
• Second and third trimesters: Target TSH 0.2 to 3.0 mIU/L [C1].
• Monitoring cadence: Recheck TSH every four weeks until mid-pregnancy, then at least once between 26 and 32 weeks [C1].
• Postpartum: Return to the pre-pregnancy dose immediately after delivery and recheck TSH in 6 weeks [C1].

The 2010 THERAPY trial by Yassa and colleagues showed that pre-emptively adding two extra levothyroxine tablets per week as soon as pregnancy was confirmed reduced the proportion of women with TSH above target in the first trimester from 65% to about 17% [C2]. The ATA endorses this empiric approach when same-day endocrinology contact isn't feasible [C1].

What undertreated hypothyroidism does to pregnancy

This is the reason the guideline is so explicit. Untreated or undertreated maternal hypothyroidism is associated with [C1][C8]:

• Miscarriage, particularly first-trimester loss
• Preterm birth
• Gestational hypertension and pre-eclampsia
• Low birth weight
• Placental abruption
• Reduced infant IQ in observational studies of moderate-to-severe maternal hypothyroidism

The 2017 Casey trial in NEJM tested whether treating mild subclinical hypothyroidism (TSH 4.0–10) found on routine prenatal screening improved child cognition at age 5. It did not — the trial enrolled later in pregnancy than the developmental window most affected, suggesting treatment timing matters [C5]. The takeaway is not "treatment doesn't help" but "treat early, ideally before conception" [C1][C5].

What about Hashimoto's specifically

TPO-antibody-positive women, even with normal TSH, face a higher risk of pregnancy complications and progression to overt hypothyroidism during pregnancy [C1][C8]. The ATA recommends [C1]:

• TSH check before pregnancy in known TPO-positive women
• Earlier and more frequent monitoring if TSH is at the upper end of normal
• Lower treatment threshold — starting levothyroxine if TSH is above 2.5 mIU/L in TPO-positive women trying to conceive or pregnant, versus 4.0 in antibody-negative women

This is the population where the "TPO antibodies matter even with normal TSH" point becomes most concrete.

Iodine in pregnancy

Iodine demand rises 50% in pregnancy because the fetus needs it and renal losses increase [C1][C7]. The American Thyroid Association recommends 250 mcg/day total iodine in pregnancy and lactation, with most women advised to take a prenatal vitamin containing 150 mcg/day in addition to dietary iodine [C1][C7]. The NIH Office of Dietary Supplements supports the same target [C7].

Important caveat: more is not better. Iodine intake above 500–1100 mcg/day can paradoxically cause hypothyroidism in the developing fetus through the Wolff-Chaikoff effect [C7]. Avoid kelp supplements, "thyroid support" blends, and seaweed-heavy diets during pregnancy.

Practical guidelines

1. Plan thyroid optimization before conception. Target TSH <2.5 mIU/L if you're on levothyroxine. Ask for a check 3 months before trying to conceive [C1].
2. Confirm pregnancy → contact your endocrinologist that day. Many practices have a standing protocol to add two extra levothyroxine tablets per week (an effective ~29% increase) until labs are rechecked [C1][C2].
3. Recheck TSH every 4 weeks through week 20. Then at least once between weeks 26 and 32 [C1].
4. Take levothyroxine separately from prenatal iron and calcium. Both impair absorption. Separate by at least four hours [C1].
5. After delivery, return to pre-pregnancy dose immediately. Recheck TSH at 6 weeks postpartum [C1]. Postpartum thyroiditis is more common in TPO-positive women and warrants attention if symptoms appear.
6. Choose a prenatal vitamin with 150 mcg iodine. Avoid kelp or seaweed-based "natural" iodine products [C1][C7].

Frequently asked questions

Is levothyroxine safe in pregnancy? Yes. Levothyroxine is identical to the T4 your thyroid would normally produce and is considered safe and necessary in pregnancy when needed [C1][C6]. The ATA and obstetric organizations explicitly recommend continuing or starting levothyroxine in pregnant women who need it [C1].

Will my dose stay higher after delivery? No. After delivery, levothyroxine needs typically return to pre-pregnancy levels within days. The ATA recommends going back to the original dose immediately after delivery and rechecking TSH at 6 weeks postpartum [C1].

What if I find out I'm pregnant after weeks of being undertreated? Contact your obstetrician and endocrinologist immediately. Get a TSH and free T4 right away. The dose can be corrected promptly — earlier is better, but late is much better than never [C1].

Can I take liothyronine (T3) in pregnancy? No. The ATA explicitly recommends against T3-containing therapy (liothyronine or desiccated thyroid) in pregnancy. T3 does not cross the placenta well and the fetus depends on maternal T4 [C1]. If you're on T3-containing therapy and become pregnant, your endocrinologist will switch you to levothyroxine.

Why does the TSH target matter so much in the first trimester? The fetal brain depends entirely on maternal T4 until weeks 16–20 [C1]. Higher TSH means lower available T4 — and the developmental window is short [C1][C5].

Bottom line

If you're on levothyroxine and become pregnant, your dose almost certainly needs to go up — typically 20–50% by the first trimester [C1][C2]. The ATA recommends empirically adding two extra tablets per week as soon as pregnancy is confirmed, with TSH rechecked every four weeks through mid-pregnancy, targeting <2.5 mIU/L in the first trimester [C1]. Iodine intake should rise to 250 mcg/day from prenatal vitamins, but not from kelp [C7]. After delivery, return to pre-pregnancy dose immediately [C1]. Get the planning visit before conception if you can — it's the single highest-leverage step in this whole process.

Sources

1. [C1] Alexander EK, Pearce EN, Brent GA, et al. 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. Thyroid. 2017;27(3):315–389. PubMed: 28056690
2. [C2] Yassa L, Marqusee E, Fawcett R, Alexander EK. Thyroid hormone early adjustment in pregnancy (the THERAPY trial). J Clin Endocrinol Metab. 2010;95(7):3234–3241. PubMed: 20463094
3. [C3] Abalovich M, Alcaraz G, Kleiman-Rubinsztein J, et al. The relationship of preconception thyrotropin levels to requirements for increasing the levothyroxine dose during pregnancy in women with primary hypothyroidism. Thyroid. 2010;20(10):1175–1178. PubMed: 20860419
4. [C4] Stagnaro-Green A, Abalovich M, Alexander E, et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid. 2011;21(10):1081–1125. PubMed: 21787128
5. [C5] Casey BM, Thom EA, Peaceman AM, et al. Treatment of Subclinical Hypothyroidism or Hypothyroxinemia in Pregnancy. N Engl J Med. 2017;376(9):815–825. PubMed: 28249134
6. [C6] American Thyroid Association. Thyroid Disease and Pregnancy — Patient Information. thyroid.org
7. [C7] NIH Office of Dietary Supplements. Iodine — Fact Sheet for Health Professionals. ods.od.nih.gov
8. [C8] Mannisto T, Mendola P, Grewal J, et al. Thyroid diseases and adverse pregnancy outcomes in a contemporary US cohort. J Clin Endocrinol Metab. 2013;98(7):2725–2733. PubMed search: find paper

---

For educational purposes only. Not medical advice. Always consult your healthcare provider.